GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,063,000 | -0.1% | 414,952 | -0.0% | 0.14% | +17.1% |
| Q1 2022 | $18,075,000 | -2.0% | 414,956 | -0.8% | 0.12% | 0.0% |
| Q4 2021 | $18,452,000 | +14.7% | 418,402 | -0.7% | 0.12% | +8.3% |
| Q3 2021 | $16,094,000 | -13.1% | 421,212 | -9.4% | 0.11% | -10.7% |
| Q2 2021 | $18,518,000 | +10.6% | 465,062 | -0.8% | 0.12% | +7.1% |
| Q1 2021 | $16,737,000 | -3.2% | 468,962 | -0.2% | 0.11% | -10.3% |
| Q4 2020 | $17,299,000 | -14.2% | 470,102 | -12.2% | 0.13% | -27.2% |
| Q3 2020 | $20,155,000 | -7.8% | 535,474 | -0.1% | 0.17% | -10.8% |
| Q2 2020 | $21,866,000 | +7.7% | 536,062 | 0.0% | 0.19% | -11.0% |
| Q1 2020 | $20,311,000 | -19.8% | 536,062 | -0.5% | 0.22% | +11.2% |
| Q4 2019 | $25,317,000 | +8.2% | 538,762 | -1.8% | 0.20% | +1.6% |
| Q3 2019 | $23,404,000 | +6.6% | 548,362 | 0.0% | 0.19% | -6.3% |
| Q2 2019 | $21,945,000 | -4.5% | 548,362 | -0.3% | 0.21% | -8.8% |
| Q1 2019 | $22,977,000 | +9.3% | 549,818 | -0.0% | 0.23% | -2.2% |
| Q4 2018 | $21,014,000 | -13.1% | 549,961 | -8.6% | 0.23% | +5.5% |
| Q3 2018 | $24,171,000 | -8.4% | 601,699 | -8.1% | 0.22% | -11.3% |
| Q2 2018 | $26,400,000 | +3.3% | 654,937 | +0.1% | 0.25% | -0.8% |
| Q1 2018 | $25,560,000 | +10.2% | 654,213 | +0.0% | 0.25% | +15.3% |
| Q4 2017 | $23,201,000 | -14.1% | 654,113 | -1.7% | 0.22% | -19.7% |
| Q3 2017 | $27,014,000 | -5.8% | 665,372 | -0.0% | 0.27% | -12.4% |
| Q2 2017 | $28,692,000 | +2.0% | 665,416 | -0.2% | 0.31% | +2.0% |
| Q1 2017 | $28,117,000 | +9.5% | 666,904 | +0.0% | 0.30% | +4.5% |
| Q4 2016 | $25,679,000 | -10.9% | 666,804 | -0.3% | 0.29% | -16.8% |
| Q3 2016 | $28,836,000 | -0.5% | 668,604 | 0.0% | 0.35% | -6.0% |
| Q2 2016 | $28,977,000 | +7.7% | 668,604 | +0.7% | 0.37% | -0.8% |
| Q1 2016 | $26,914,000 | -20.6% | 663,729 | -21.0% | 0.37% | -21.1% |
| Q4 2015 | $33,907,000 | +4.9% | 840,329 | 0.0% | 0.47% | -4.5% |
| Q3 2015 | $32,310,000 | -7.8% | 840,329 | -0.1% | 0.49% | +5.1% |
| Q2 2015 | $35,037,000 | -9.7% | 841,229 | 0.0% | 0.47% | -15.1% |
| Q1 2015 | $38,822,000 | +8.7% | 841,229 | +0.7% | 0.55% | +6.4% |
| Q4 2014 | $35,703,000 | -7.2% | 835,358 | -0.2% | 0.52% | -12.8% |
| Q3 2014 | $38,462,000 | -36.7% | 836,679 | -26.4% | 0.59% | -34.9% |
| Q2 2014 | $60,798,000 | -0.0% | 1,136,849 | -0.1% | 0.91% | -5.8% |
| Q1 2014 | $60,826,000 | +0.1% | 1,138,418 | 0.0% | 0.97% | -4.0% |
| Q4 2013 | $60,780,000 | +6.3% | 1,138,418 | -0.1% | 1.01% | -8.3% |
| Q3 2013 | $57,178,000 | -7.4% | 1,139,698 | -7.8% | 1.10% | -15.7% |
| Q2 2013 | $61,738,000 | – | 1,235,509 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |